Live Breaking News & Updates on Model Informed Drug Development Approaches

Stay updated with breaking news from Model informed drug development approaches. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alston & Bird Health Care Week in Review - May 2021 #3 | Alston & Bird


Below is
Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, the Senate Finance Committee discussed making permanent COVID-19 flexibilities, including those related to telehealth. See the hearing and other news below.
I.Regulations, Notices & Guidance 
On May 19, 2021, the Food and Drug Administration (FDA) issued draft guidance entitled,
Feasibility Clinical Studies for Certain Medical Devices Intended to Therapeutically Improve Glycemic Control in Patients with Type 2 Diabetes Mellitus. The draft guidance provides recommendations for feasibility and early feasibility clinical studies for certain medical devices intended to therapeutically improve glycemic control in patients with Type 2 Diabetes Melli ....

United States , Kisha Davis , Narayana Murali , Jessica Farb , Kimberly Glas , David Skorton , Khalil Shahyd , Rachael Eubanks , Shereef Elnahal , Ahmer Qadeer , Kadrian Moore , Robert Berenson , Beth Mccracken , Robert Handfield , James Herbert , Rodney Hochman , Stephen Schondelmeyer , Michael Novogradac , Heather Buch , Brian Miller , Linda Decherrie , Martin Gaynor , Joseph Kile , Stephen Lewis , Shirley Bloomfield , National Association Of Counties ,

Alston & Bird Health Care Week in Review - May 2021 #1 | Alston & Bird


Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, HHS announced several efforts to boost COVID-19 vaccination rates in the U.S. Read more about these initiatives and other news below.
I. Regulations, Notices & Guidance
Event Notices
May 11-12, 2021: The Food and Drug Administration (FDA) announced a public meeting entitled,
Meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee. The general function of the subcommittee is to provide advice and recommendations to FDA on regulatory issues. ....

United States , Seth Karp , Ayanna Pressley , Tonya Ingram , Donna Cryer , Joia Adele Crear Perry , Rachel Sachs , Laquayia Goldring , Xavier Becerra , Douglas Holtz Eakin , Joe Ferreira , Matt Wadsworth , Jamila Taylor , Charles Johnson , Khrystal Davis , Tatyana Ali , Tamika Auguste , Gaurav Gupta , Dara Kass , David Mitchell , Steve Miller , Veronica Gillispie , Almas Adams , Frederick Isasi , Health Resources , House Committee On Education ,

Alston & Bird Health Care Week in Review - April 2021 #5 | Alston & Bird


Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, CMS released its FY 2022 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Rates Proposed Rule. Read more about the rule and other news below.
I. Regulations, Notices & Guidance
On April 26, 2021, the Food and Drug Administration (FDA) issued guidance entitled,
Nonclinical Testing of Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases; Draft Guidance for Sponsor-Investigators. FDA is publishing this draft guidance to help sponsor-investigators with developing the nonclinical information that FDA recommends to support an investigational new drug application (IND) f ....

United States , South Carolina , San Francisco , Randy Keller , Natalie Hakala , Carolyn Maloney , Francis Collins , Mike Lee , Leemore Dafny , Sara Goldsby , Alden Abbott , Tami Benton , Sinsi Hernandez Cancio , Lisa Mccorkell , Thomas Kim , Ateev Mehrotra , Amy Klobuchar , Eugenes Farley Jr , Joel White , Linda Perryman Evans , Steven Deeks , Chuck Grassley , Jennifer Possick , Robin Feldman , John Brooks , Ellen Kelsay ,

Alston & Bird Health Care Week in Review - April 2021 #4 | Alston & Bird


Below is Alston & Bird’s
Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
Week in Review Highlight of the Week:
This week, HHS announced it is providing $150 million to community-based health care providers to aid their response to COVID-19. Read more about this funding and other news below.
I. Regulations, Notices & Guidance
On April 21, 2021, the Department of Health and Human Services (HHS) issued a final rule entitled,
National Vaccine Injury Compensation Program: Rescission of Revisions to the Vaccine Injury Table. This action rescinds in its entirety the rule entitled “National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table,” published in the Federal Register on January 21, 2021. ....

United States , Candice Wright , Michael Lauer , Elisa Aguirre , Gary Cantrell , National Vaccine Injury Compensation Program , Health Resources , Office Of Inspector , Senate Committee On , Technology Assessment , Quality Transparency In Health Care , Other Health Policy News , Meeting Of The National Vaccine Advisory Committee , Medicare Program , Department Of Health , Health Equity Task , Congressional Budget Office , Office Of National Security , Centers For Disease , Centers For Medicare Medicaid Service , Centers For Medicare Medicaid Services , Us Senate , Research Initiatives Workshop , Human Services , Mental Health Services Administration , Drug Administration ,